149 related articles for article (PubMed ID: 22528132)
1. Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss.
Canis M; Heigl F; Suckfuell M
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):36-40. PubMed ID: 22528132
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients.
Heigl F; Hettich R; Suckfuell M; Luebbers CW; Osterkorn D; Osterkorn K; Canis M
Atheroscler Suppl; 2009 Dec; 10(5):95-101. PubMed ID: 20129384
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial].
Suckfüll M; Seidel D; Thiery J; Mazurek B; Jaehne M; Gronemeyer J; Reichel O; Sasama J; Kichigina S; Möller M; Beil FU; Schrameyer-Wernecke A; Kassner U; Koch M; Jaeger B; Osterkorn K; Osterkorn D
Z Kardiol; 2003; 92(Suppl 3):III59-63. PubMed ID: 14663604
[TBL] [Abstract][Full Text] [Related]
4. Rheopheresis for sudden sensorineural hearing loss.
Klingel R; Heibges A; Uygun-Kiehne S; Fassbender C; Mösges R
Atheroscler Suppl; 2009 Dec; 10(5):102-6. PubMed ID: 20129385
[TBL] [Abstract][Full Text] [Related]
5. [Fibrinogen/LDL apheresis for treatment of sudden hearing loss: an observational study on 152 patients].
Canis M; Heigl F; Hettich R; Osterkorn D; Osterkorn K; Suckfuell M
HNO; 2008 Sep; 56(9):961-6. PubMed ID: 18719869
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen is not a prognostic factor for response to HELP-apheresis in sudden sensorineural hearing loss (SSHL).
Berger T; Kaiser T; Scholz M; Bachmann A; Ceglarek U; Hesse G; Hagemeyer B; Stumvoll M; Thiery J; Dietz A
Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3693-703. PubMed ID: 25527412
[TBL] [Abstract][Full Text] [Related]
7. Treatment with HELP-apheresis in patients suffering from sudden sensorineural hearing loss: a prospective, randomized, controlled study.
Bianchin G; Russi G; Romano N; Fioravanti P
Laryngoscope; 2010 Apr; 120(4):800-7. PubMed ID: 20213795
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial.
Suckfüll M;
Lancet; 2002 Dec; 360(9348):1811-7. PubMed ID: 12480357
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of sudden sensorineural hearing loss (SSHL) with HELP-apheresis: our experience].
Russi G; Bianchin G; Romano N; Canovi L; Polizzi V; Scarano L
G Ital Nefrol; 2012; 29 Suppl 54():S138-40. PubMed ID: 22388846
[TBL] [Abstract][Full Text] [Related]
10. [Apheresis decreases LDL and fibrinogen. Rapid treatment in sudden deafness].
MMW Fortschr Med; 2002 Apr; 144(15):64. PubMed ID: 12013034
[No Abstract] [Full Text] [Related]
11. Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?
Ramunni A; Quaranta N; Saliani MT; Fallacara RA; Ria R; Ranieri G
Ther Apher Dial; 2006 Jun; 10(3):282-6. PubMed ID: 16817795
[TBL] [Abstract][Full Text] [Related]
12. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
Suckfüll M
Ther Apher; 2001 Oct; 5(5):377-83. PubMed ID: 11778923
[TBL] [Abstract][Full Text] [Related]
13. [Hypercholesteremia and hyperfibrinogenemia in sudden deafness].
Suckfüll M; Thiery J; Wimmer C; Mees K; Schorn K
Laryngorhinootologie; 1997 Aug; 76(8):453-7. PubMed ID: 9376027
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study.
Suckfüll M; Thiery J; Schorn K; Kastenbauer E; Seidel D
Acta Otolaryngol; 1999; 119(7):763-6. PubMed ID: 10687932
[TBL] [Abstract][Full Text] [Related]
15. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness].
Walch C; Anderhuber W; Walzl M
Laryngorhinootologie; 1996 Nov; 75(11):641-5. PubMed ID: 9063830
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of rheopheresis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss.
Balletshofer BM; Stock J; Rittig K; Lehn-Stefan A; Braun N; Burkart F; Plontke S; Klingel R; Häring HU
Ther Apher Dial; 2005 Oct; 9(5):385-90. PubMed ID: 16202012
[TBL] [Abstract][Full Text] [Related]
17. The Role of Hyperbaric Oxygen as Salvage Therapy for Sudden Sensorineural Hearing Loss.
Almosnino G; Holm JR; Schwartz SR; Zeitler DM
Ann Otol Rhinol Laryngol; 2018 Oct; 127(10):672-676. PubMed ID: 30009614
[TBL] [Abstract][Full Text] [Related]
18. Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis.
Ullrich H; Kleinjung T; Steffens T; Jacob P; Schmitz G; Strutz J
J Clin Apher; 2004; 19(2):71-8. PubMed ID: 15274199
[TBL] [Abstract][Full Text] [Related]
19. Role of H.E.L.P.-apheresis in the treatment of sudden sensorineural hearing loss in a group of 230 patients.
Bianchin G; Russi G; Romano N; Fioravanti P
Acta Otorhinolaryngol Ital; 2011 Dec; 31(6):395-8. PubMed ID: 22323851
[No Abstract] [Full Text] [Related]
20. LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis.
Kobayashi S; Oka M; Moriya H; Maesato K; Okamoto K; Ohtake T
Ther Apher Dial; 2006 Jun; 10(3):219-23. PubMed ID: 16817784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
